I.E. MEDICA, INC.
I.E. Medica was established as a pharmaceutical company engaged in global sourcing, registration, importation, and supply of pharmaceutical products to various marketing and distribution partners in the Philippines. Our global network of US-FDA, UK-MHRA and WHO-GMP certified manufacturers enabled us to bring the latest healthcare solutions to the Philippine market. Over the years, IE Medica has become a leading source of newly off-patent generic molecules, innovative drug delivery systems, and unique fixed-dose combinations.
See below for the Latest I.E MEDICA, INC News, Analysis, Profit Results, Share Price Information, and Commentary.
Healthcare Asia Pharma Awards 2024 Winner: I.E. MEDICA, INC.
                                                                                 
                    
                    Ma. Victoria P. Sugapong, Chief Operating Officer of I.E. Medica, celebrates their Level 1 AEO accreditation, emphasising its significance in enhancing trade efficiency and solidifying their position as a trusted healthcare provider. 
                
                                
            Healthcare Asia Pharma Awards 2024 Winner: I.E. MEDICA, INC.
                                                                                                                 
                            
                            Ma. Victoria P. Sugapong, Chief Operating Officer of I.E. Medica, celebrates their Level 1 AEO accreditation, emphasising its significance in enhancing trade efficiency and solidifying their position as a trusted healthcare provider. 
                        
                                                
                        
    
                    I.E. Medica bags Healthcare Asia Pharma Awards for supply chain initiative
                                                                                                 
                        
                        Its potential accreditation for AEO can enhance the nation’s supply chain requirements.
                    
                                        
                    
                 
            	         
                	         
                             
           
                                 
                                 
                                 
               
                                     
                                     
                                     
 
                                                                                                
                                                
                                                                                                                                         
 
                                                                                                
                                                
                                                                                                                                         
 
                                                                                                
                                                
                                                                                                                                         
 
                                                                                                
                                                
                                                                                                                                         
                 
                 
                 
                 
                 
                 
                